Placeholder

Fame Podcast Host

Patrick Short
“We are getting close to a ‘tipping point’ in genomics and medicine where it will make economic sense to DNA sequence everyone. The reason for this is that there is mounting evidence of the value of this data in both rare and common diseases. As a genetic test only needs to be completed once, soon the benefits will outweigh the costs on a population / healthcare system level. This will spur even more innovation in the ‘application layer’ including the development of new genetically targeted medicines and in prediction and prevention of common diseases like type 2 diabetes, breast cancer, and cardiovascular disease."

Patrick is the CEO and co-founder of Sano Genetics, a company accelerating precision medicine research into chronic and rare genetic diseases. Their mission is to accelerate the future of personalized medicine.

<iframe id="bCastiFrm68rm43xn" src="https://player.bcast.fm/the-genetics-podcast/68rm43xn" frameborder="0" height="180" seamless="true" style="width:100%;height:180px;" width="100%"></iframe>

Prior to founding Sano, Patrick was a researcher at the Wellcome Sanger Institute at the University of Cambridge where he focused on large-scale genome sequencing projects and rare disorders. A University of Cambridge alumnus, Patrick holds a PhD in Mathematical Genomics and Medicine.

<iframe id="bCastiFrm1n2jp96n" src="https://player.bcast.fm/the-genetics-podcast/1n2jp96n-rare-disease-genetics-caroline-wright" frameborder="0" height="180" seamless="true" style="width:100%;height:180px;" width="100%"></iframe>

Patrick hosts The Genetics Podcast where he analyzes the science, interviews the experts, and discusses the latest findings and breakthroughs in genetic research.

<iframe id="bCastiFrmqn03rv28" src="https://player.bcast.fm/the-genetics-podcast/qn03rv28-integrating-genomics-konstantinos-lazaridis" frameborder="0" height="180" seamless="true" style="width:100%;height:180px;" width="100%"></iframe>

Ask me

  • 1

    What was the impetus behind founding Sano Genetics?

  • 2

    ​​What is the significance of accelerating the advancement of personalized medicine, and how does Sano Genetics contribute to the rapid progression of this field?

  • 3

    How does the Sano Genetics platform streamline the process of conducting personalized medicine research, and what are the key features that facilitate interactions among researchers, patients, and other stakeholders within the platform?

  • 4

    Is there notable advancement in the healthcare sector toward providing personalized medicine, and what part does Sano play in this movement?

Book this host as your guest

This podcast host has been trained by our team of podcast ninjas. They know how to transform a podcast interview into an addictive piece of audio....